Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1973 Sep;15(1):53–63.

Complement activation in pemphigus vulgaris blister fluid*

R E Jordon, N K Day, J R Luckasen, R A Good
PMCID: PMC1553867  PMID: 4765721

Abstract

Total haemolytic complement was reduced in blister fluids of four pemphigus vulgaris patients when compared to serum complement levels and other serum and blister fluid proteins. Complement levels in most control blister fluids, on the other hand, more closely approached their corresponding serum levels. Haemolytic C1, C4, C2, C3 and C5, measured in two pemphigus sera and blister fluids, were not measurable in one blister fluid and were extremely low in the second patient. C3 proactivator (C3PA) was absent from both of these blister fluids. Three of the blister fluids exhibited anti-complementary activity when tested with normal human serum. By adding one blister fluid to normal human serum, inhibition of haemolytic C1, C2, C3 and C5 with conversion of C3 and C3PA occurred. Activation of complement locally in pemphigus blister fluids would suggest a pathogenetic role for complement in this disease.

Full text

PDF
58

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BEUTNER E. H., JORDON R. E. DEMONSTRATION OF SKIN ANTIBODIES IN SERA OF PEMPHIGUS VULGARIS PATIENTS BY INDIRECT IMMUNOFLUORESCENT STAINING. Proc Soc Exp Biol Med. 1964 Nov;117:505–510. doi: 10.3181/00379727-117-29622. [DOI] [PubMed] [Google Scholar]
  2. BEUTNER E. H., LEVER W. F., WITEBSKY E., JORDON R., CHERTOCK B. AUTOANTIBODIES IN PEMPHIGUS VULGARIS: RESPONSE TO AN INTERCELLULAR SUBSTANCE OF EPIDERMIS. JAMA. 1965 May 24;192:682–688. doi: 10.1001/jama.1965.03080210026006. [DOI] [PubMed] [Google Scholar]
  3. Borsos T., Rapp H. J. Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement. J Immunol. 1967 Aug;99(2):263–268. [PubMed] [Google Scholar]
  4. Cormane R. H., Chorzelski T. P. "Bound" complement in the epidermis of patients with pemphigus vulgaris. Dermatologica. 1967;134(6):463–466. doi: 10.1159/000254290. [DOI] [PubMed] [Google Scholar]
  5. Cram D. L., Fukuyama K. Immunohistochemistry of ultraviolet-induced pemphigus and pemphigoid lesions. Arch Dermatol. 1972 Dec;106(6):819–824. [PubMed] [Google Scholar]
  6. Day N. K., Geiger H., Stroud R., DeBracco M., Mancaido B., Windhorst D., Good R. A. C1r deficiency: an inborn error associated with cutaneous and renal disease. J Clin Invest. 1972 May;51(5):1102–1108. doi: 10.1172/JCI106902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gewurz H., Page A. R., Pickering R. J., Good R. A. Complement activity and inflammatory neutrophil exudation in man. Studies in patients with glomerulonephritis, essential hypocomplementemia and agammaglobulinemia. Int Arch Allergy Appl Immunol. 1967;32(1):64–90. doi: 10.1159/000229917. [DOI] [PubMed] [Google Scholar]
  8. Götze O., Müller-Eberhard H. J. The C3-activator system: an alternate pathway of complement activation. J Exp Med. 1971 Sep 1;134(3 Pt 2):90s–108s. [PubMed] [Google Scholar]
  9. Jordon R. E., Day N. K., Sams W. M., Jr, Good R. A. The complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids. J Clin Invest. 1973 May;52(5):1207–1214. doi: 10.1172/JCI107288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jordon R. E., Sams W. M., Jr, Beutner E. H. Complement immunofluorescent staining in bullous pemphigoid. J Lab Clin Med. 1969 Oct;74(4):548–556. [PubMed] [Google Scholar]
  11. Jordon R. E., Sams W. M., Jr, Diaz G., Beutner E. H. Negative complement immunofluorescence in pemphigus. J Invest Dermatol. 1971 Dec;57(6):407–410. doi: 10.1111/1523-1747.ep12293273. [DOI] [PubMed] [Google Scholar]
  12. Jordon R. E., Triftshauser C. T., Schroeter A. L. Direct immunofluorescent studies of pemphigus and bullous pemphigoid. Arch Dermatol. 1971 May;103(5):486–491. doi: 10.1001/archderm.103.5.486. [DOI] [PubMed] [Google Scholar]
  13. LIM S. D., FUSARO R. M. Pemphigus vulgaris. II. An abnormal protein of blister fluid and serum demonstrable by immuno-electrophoresis. J Invest Dermatol. 1963 Apr;40:173–176. doi: 10.1038/jid.1963.33. [DOI] [PubMed] [Google Scholar]
  14. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  15. Müller-Eberhard H. J. Chemistry and reaction mechanisms of complement. Adv Immunol. 1968;8:1–80. doi: 10.1016/s0065-2776(08)60464-2. [DOI] [PubMed] [Google Scholar]
  16. Müller-Eberhard H. J., Götze O. C3 proactivator convertase and its mode of action. J Exp Med. 1972 Apr 1;135(4):1003–1008. doi: 10.1084/jem.135.4.1003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Nelson R. A., Jr, Jensen J., Gigli I., Tamura N. Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum. Immunochemistry. 1966 Mar;3(2):111–135. doi: 10.1016/0019-2791(66)90292-8. [DOI] [PubMed] [Google Scholar]
  18. Ruddy S., Gigli I., Austen K. F. The complement system of man. I. N Engl J Med. 1972 Sep 7;287(10):489–495. doi: 10.1056/NEJM197209072871005. [DOI] [PubMed] [Google Scholar]
  19. van Joost T., Cormane R. H., Pondman K. W. Direct immunofluorescent study of the skin on occurrence of complement in pemphigus. Br J Dermatol. 1972 Nov;87(5):466–474. doi: 10.1111/j.1365-2133.1972.tb01595.x. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES